News Pacira CEO hopes for further expansion to US nerve block lab... CEO wants "broad nerve block label" for Exparel
News FDA approves Indivior's long-lasting opioid withdrawal thera... Monthly injection will help addicts manage withdrawal symptoms
News FDA encourages cheap abuse-deterrent painkillers Regulator waiting for non-opioid alternatives to reach the market
News Daiichi Sankyo denies AstraZeneca takeover report Japanese pharma also hands back rights to painkiller to US biotech.
News Sanofi drops two more programmes in R&D clear-out Shortly after terminating one late-stage R&D programme, Sanofi confirmed in its second-quarter update that two others are being scrapped.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
